WHO ICTRP trial

Develop a tool for assessment of poor metabolic activities and to assess the…

CTRI/2023/06/054339 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2023/06/054339
Public title Develop a tool for assessment of poor metabolic activities and to assess the level of inflammatory markers before and after giving Musta (Cyperus rotundus) hot infusion in Primary myelofibrosis
Scientific title Study to develop a validated tool for the assessment of ama, and to assess the effect of amapachana medicines - Musta (Cyperus rotundus Linn.) as add on to conventional treatments in patients of Primary Myelofibrosis and the expression of inflammatory markers at molecular level â?? An open label…
Primary sponsor All India Institute of Ayurveda
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2/ Phase 3
Countries India
Conditions Health Condition 1: D471- Chronic myeloproliferative disease
Registration date Jun 22, 2023
Target size 60
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations